Remove 2023 Remove Communication Remove Labelling
article thumbnail

Labelling of Dispensed Medicine

RX Note

Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. NOTE: It is advisable for labels to be printed. Consequently, a patient-centred label strategy is introduced to promote appropriate medication use and adherence. Suggestions include Use larger font sizes (e.g.

article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

In the US Drug Quality and Security Act (DSCSA), the FDA mandates that manufacturers and trading partners should have full interoperable electronic track and trace systems in place by November 2023. RFID is an important facet of smart labelling and its evolution, but not the only one.

Labelling 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Express Pharma

As of 2023, adult obesity prevalence in India stood at around 6.5 Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. per cent, affecting nearly 100 million people (13).

Diabetes 101
article thumbnail

FDA’s OPDP Issues Third Letter of 2023

Eye on FDA

The Untitled Letter posted this week involved an oral birth control pill which has a specific of contraindications contained in the label as well as a list of warnings and precautions and of the most common adverse events. The communications vehicle in question was a social media sponsored posting. Pharma communicators take note.

article thumbnail

It Finally Happened – FDA’s OPDP Issues First Letter of 2023

Eye on FDA

The label for the medicine includes a boxed warning regarding potential issues related to complications for the liver (toxicity) and heart (QT prolongation). Going back and looking through 2020 at the products involved in letters, there have been a total of 17 letters (involving 19 different communications vehicles).

article thumbnail

Scientific Communication for Pharma Marketing – Quiz

PharmaState Academy

This quiz competition is brought to you by Now & Next Summit on Pharma Marketing scheduled for 28th Oct 2023 at The Westin, Goregaon, Mumbai. a) 50% b) 75% c) 60% d) 90% 2 / 20 What is the potential impact of clear scientific communication on patient outcomes? How to Participate? The Quiz has to be attempted in a single go.

article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

Humira is indicated for 10 adult and pediatric conditions, including Crohn’s disease, rheumatoid arthritis, and ulcerative colitis, as per its label. Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. Temporary first-to-market advantage.